Literature DB >> 15003459

Folding and stability of the leucine-rich repeat domain of internalin B from Listeri monocytogenes.

Alexander Freiberg1, Matthias P Machner, Wolfgang Pfeil, Wolf-Dieter Schubert, Dirk W Heinz, Robert Seckler.   

Abstract

Internalin B (InlB), a surface protein of the human pathogen Listeria monocytogenes, promotes invasion into various host cell types by inducing phagocytosis of the entire bacterium. The N-terminal half of InlB (residues 36-321, InlB321), which is sufficient for this process, contains a central leucine-rich repeat (LRR) domain that is flanked by a small alpha-helical cap and an immunoglobulin (Ig)-like domain. Here we investigated the spectroscopic properties, stability and folding of InlB321 and of a shorter variant lacking the Ig-like domain (InlB248). The circular dichroism spectra of both protein variants in the far ultraviolet region are very similar, with a characteristic minimum found at approximately 200 nm, possibly resulting from the high 3(10)-helical content in the LRR domain. Upon addition of chemical denaturants, both variants unfold in single transitions with unusually high cooperativity that are fully reversible and best described by two-state equilibria. The free energies of GdmCl-induced unfolding determined from transitions at 20 degrees C are 9.9(+/-0.8)kcal/mol for InlB321 and 5.4(+/-0.4)kcal/mol for InlB248. InlB321 is also more stable against thermal denaturation, as observed by scanning calorimetry. This suggests, that the Ig-like domain, which presumably does not directly interact with the host cell receptor during bacterial invasion, plays a critical role for the in vivo stability of InlB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003459     DOI: 10.1016/j.jmb.2004.01.044

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

Review 1.  Repeat-protein folding: new insights into origins of cooperativity, stability, and topology.

Authors:  Ellen Kloss; Naomi Courtemanche; Doug Barrick
Journal:  Arch Biochem Biophys       Date:  2007-09-15       Impact factor: 4.013

2.  Folding thermodynamics and kinetics of the leucine-rich repeat domain of the virulence factor Internalin B.

Authors:  Naomi Courtemanche; Doug Barrick
Journal:  Protein Sci       Date:  2008-01       Impact factor: 6.725

3.  Thermodynamics, kinetics, and salt dependence of folding of YopM, a large leucine-rich repeat protein.

Authors:  Ellen Kloss; Doug Barrick
Journal:  J Mol Biol       Date:  2008-09-04       Impact factor: 5.469

4.  The leucine-rich repeat domain of Internalin B folds along a polarized N-terminal pathway.

Authors:  Naomi Courtemanche; Doug Barrick
Journal:  Structure       Date:  2008-05       Impact factor: 5.006

5.  C-terminal deletion of leucine-rich repeats from YopM reveals a heterogeneous distribution of stability in a cooperatively folded protein.

Authors:  Ellen Kloss; Doug Barrick
Journal:  Protein Sci       Date:  2009-09       Impact factor: 6.725

6.  Characterization of Toll-like receptor gene expression and the pathogen agonist response in the antarctic bullhead notothen Notothenia coriiceps.

Authors:  Do Hwan Ahn; Seung Chul Shin; Hyun Park
Journal:  Immunogenetics       Date:  2014-07-31       Impact factor: 2.846

7.  The unfolded protein response is required for dendrite morphogenesis.

Authors:  Xing Wei; Audrey S Howell; Xintong Dong; Caitlin A Taylor; Roshni C Cooper; Jianqi Zhang; Wei Zou; David R Sherwood; Kang Shen
Journal:  Elife       Date:  2015-06-08       Impact factor: 8.140

8.  Diffuse transition state structure for the unfolding of a leucine-rich repeat protein.

Authors:  Sadie E Kelly; Georg Meisl; Pamela J E Rowling; Stephen H McLaughlin; Tuomas Knowles; Laura S Itzhaki
Journal:  Phys Chem Chem Phys       Date:  2014-02-18       Impact factor: 3.945

9.  Crystal structure of an engineered YopM-InlB hybrid protein.

Authors:  Dennis Breitsprecher; Ermanno Gherardi; Willem M Bleymüller; Hartmut H Niemann
Journal:  BMC Struct Biol       Date:  2014-03-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.